A neurysmAl subarachnoid hemorrhage (aSAH) is a unique form of hemorrhagic stroke associated with high morbidity and mortality. Delayed cerebral ischemia (DCI) is a recognized complication of aSAH that contributes to poor outcome, 28, 31 and it occurs in approximately 30% of patients. 30 Early efforts to identify patients at risk for DCI focused on the diagnosis of large-vessel cerebral vasospasm. However, contemporary evidence suggests that DCI negatively affects outcome independent of angiographic vasospasm, suggesting that other factors are involved in the pathogenesis of DCI. and inflammatory pathways.
has led to the identification of novel risk factors involving systemic inflammation. 15, 22, 23 The contribution of nosocomial infections to systemic inflammation and subsequent DCI in patients with aSAH is not known. In this study we present a prospective cohort of patients with aSAH to evaluate the impact of nosocomial infection on the incidence of DCI.
Methods
A prospective cohort study was used to evaluate the effect of nosocomial infection on the incidence of DCI in patients with aSAH. All cases and controls were obtained from the Cerebral Aneurysm Renin Angiotensin System (CARAS) study, a prospective, blinded study designed to evaluate associations between the common genetic polymorphisms in the renin-angiotensin system and occurrence and rupture of cerebral aneurysms, development of cerebral vasospasm, and delayed cerebral ischemia, and outcome in aSAH. The study was started in December 2012 and completed enrollment in February 2015; final results are expected to be published in 2016.
Study Population
All patients presenting with aSAH to the University of Alabama at Birmingham and INOVA Health System were screened for inclusion in the CARAS study. The diagnosis of SAH was established on the basis of the admission CT scan or xanthochromia of CSF. A ruptured cerebral aneurysm was confirmed by CT angiography (CTA) or digital subtraction angiography (DSA). Exclusion criteria included age younger than 19 years and any associated genetic disease/syndrome that could account for the presence of an intracranial aneurysm (i.e., polycystic kidney disease, Turner syndrome, Noonan syndrome, Ehler-Danlos syndrome Type 4, Marfan syndrome, and neurofibromatosis Type 1), as well as systemic diseases (i.e., congestive heart failure, cirrhosis, etc.) that could affect the renin-angiotensin system. For the purposes of the current study, patients who died prior to 4 days postictus were also excluded. These patients presented with high Hunt and Hess grades and did not survive into the period of highest risk for the development of DCI.
Presence of a DCI was a secondary outcome measure in the CARAS study and all data were collected in a prospective manner. Demographic, clinical, and radiographic data were collected on all patients by the study principal investigator (C.J.G.) and co-principal investigator (P.M.F.).
general Management
Patients presenting with aSAH were treated in accordance with contemporary standards of care in the US, consisting of: intensive care unit (ICU) monitoring, treatment of hydrocephalus, early (< 48 hours) intervention for aneurysm treatment, oral nimodipine, maintenance of euvolemia, compression stockings, and sequential compression devices. Symptomatic vasospasm is treated with hyperdynamic therapy as first-line therapy. Hyperdynamic therapy includes strict avoidance of hypovolemia with a goal systolic blood pressure of more than 160 mm Hg, accomplished with either permissive hypertension or vasopressor therapy. Patients with symptomatic vasospasm refractory to medical treatment are treated in the endovascular suite with intraarterial therapy at the discretion of the neurointerventionalist. Following discharge from the ICU, patients are transferred to a neurological step-down unit and a neurosurgical ward with specialty training in patients with aSAH. Of note, patients with external ventricular drains (EVDs) are not routinely treated with prophylactic antibiotics.
nosocomial infection
Nosocomial infections included bacteremia, pneumonia, and urinary tract infections (UTIs) that were diagnosed at any point during the hospital stay; ventriculitis was considered separately. Bacteremia was defined as a positive blood culture necessitating treatment with antibiotics; positive blood cultures that were believed to be a contaminant and therefore not treated were not considered. Pneumonia was defined as a consolidation on radiographic imaging, a positive bronchoalveolar lavage (BAL), or both a radiographic consolidation and positive BAL requiring treatment with antibiotics; radiographic consolidation due to another etiology (i.e., volume overload) and BAL cultures growing normal flora that were not treated with antibiotics were not considered. A UTI was defined as a positive urine culture or positive leukocyte esterase and/or positive nitrite on a urinalysis necessitating treatment with antibiotics; positive urine cultures or urinalyses representing colonization that were not treated with antibiotics were not considered.
Ventriculitis was defined as a positive CSF culture requiring treatment with antibiotics; positive CSF cultures believed to be contaminants were not treated with antibiotics and were not considered. Analysis of CSF consisting of cell count, glucose, protein, and culture are routinely sent on Monday, Wednesday, and Friday in all patients with an EVD.
Nosocomial infections were counted per patient. Thus, a patient with more than 1 nosocomial infection (i.e., UTI and pneumonia) was counted only once. However, a patient who developed a nosocomial infection (pneumonia, UTI, or bacteremia) and ventriculitis would be included twice, once in the nosocomial infection group and once in the ventriculitis group. When comparing the date of diagnosis of nosocomial infection or ventriculitis to the date of diagnosis of DCI, only the initial infection was considered.
vasospasm
Angiographic vasospasm is defined as arterial narrowing appreciated on computed tomography angiography (CTA) or digital subtraction angiography (DSA) not due to atherosclerosis, catheter-induced vasospasm, or vessel hypoplasia. Additionally, vasospasm could be diagnosed with transcranial Doppler ultrasonography (TCD) findings of a peak systolic middle cerebral artery greater than 120 mm Hg with a Lindegaard ratio greater than 3; TCD data are presented separately and not included in angiographic vasospasm. CTA, DSA, and TCD were used at the discretion of critical care and neurosurgical staff; not all patients were screened for angiographic vasospasm.
Clinical vasospasm was defined as the development of a new focal or global neurological deficit, or deterioration of at least 2 points on the Glasgow Coma Scale (GCS), not explained by another clinical process including hydrocephalus, aneurysm rerupture, electrolyte disturbance, seizure, infection, fever, metabolic disturbance, cerebral edema, and surgical complication.
Delayed Cerebral Ischemia
CT and MR images were obtained due to clinical concern at the discretion of the critical care team and neurosurgical staff and routinely performed when the patient was deemed stable for transfer from the ICU to the ward. All patients were screened for DCI. Delayed cerebral ischemia was defined as low-density areas on CT that correspond to a vascular distribution or an MR image demonstrating a hyperintense area on a diffusion-weighted imaging sequence with a corresponding hypointense apparent diffusion coefficient sequence correlate that corresponds with a vascular territory. Infarctions or contusion noted on postoperative Day 1 imaging were considered procedurally related and were not considered DCI. Infarctions identified after postoperative Day 1 were considered DCI.
CT, CTA, and MRI were performed by trained technicians, interpreted by a neuroradiologist, and reviewed by neurosurgical staff. DSA was performed and interpreted by specialty-trained neurointerventionalists. TCD was performed by trained technicians and interpreted by specialty-trained neurosonologists. Disagreements were resolved though discussion of findings, with a final decision by the senior author (C.J.G.).
statistical analysis
Statistical analysis was performed using R version 3.1.1 (http://www.r-project.org). In univariate analysis, variables were compared between groups by the Wilcoxon rank-sum test for numerical variables and chi-square test for categorical variables. Statistical significance was defined as p < 0.05. Multivariate logistic regression was performed on candidate predictor variables to identify variables independently associated with DCI after controlling for potential confounders. Any variable associated with a p value around or below 0.1 in univariate analysis was included. Efforts to account for interactions and collinearity between variables were undertaken.
results
One hundred fifty-six patients with confirmed aSAH were enrolled in the CARAS study from December 2012 to February 2015. Of these 156 patients, 3 were excluded due to early death (< 4 days postictus), leaving 153 patients for analysis in the current study. Patient characteristics are presented in Table 1 . Thirty-two patients (20.9%) suffered DCI. Sixty-three patients (41.2%) experienced a nosocomial infection (pneumonia, UTI, or bacteremia) and 4 patients (2.6%) experienced ventriculitis. Aneurysm re-rupture occurred in 8 patients (5.2%).
Twenty-one (65.6%) of the patients with DCI were also diagnosed with a nosocomial infection. The diagnosis of infection preceded the diagnosis of DCI in 15 patients (71.4%) by an average of 4.7 days. Three (9.4%) of the patients with DCI were also diagnosed with ventriculitis; the diagnosis of ventriculitis preceded the diagnosis of DCI in 1 patient. Five (15.6%) of the 32 patients with DCI experienced aneurysm re-rupture.
Clinical vasospasm occurred in 35 (22.9%) of the 153 patients in this study. Twenty-five (78.1%) of the 32 patients with DCI were also diagnosed with clinical vasospasm.
risk Factors for Dci

Univariate Analysis
Patients diagnosed with DCI were significantly more likely to have a lower GCS score (p = 0.03) and a higher Hunt and Hess grade (p = 0.01). Patients with DCI were also more likely to present more than 2 days from the onset of symptoms (p = 0.05), demonstrate evidence of cerebral edema on CT (p < 0.01), require intubation (p < 0.01), receive an antiepileptic drug (p = 0.01), and experience aneurysm re-rupture (p = 0.01).
Forty-two patients (34.7%) without DCI and 21 (65.6%) with DCI were diagnosed with a nosocomial infection that required treatment with antibiotics (p < 0.01). One (0.8%) patient without DCI and 3 (9.4%) with DCI were diagnosed with ventriculitis that required treatment with antibiotics (p = 0.04).
Angiographic and clinical vasospasm were significantly associated with the development of DCI (p < 0.01). Confirmation of the diagnosis of vasospasm by CTA or DSA was not available for 89 patients without DCI and 12 patients with DCI. Evidence of vasospasm by TCD measurements was not significantly associated with DCI (p = 0.15); TCD data were not available for 70 patients without DCI and 18 patients with DCI (Table 1) .
Multivariate Analysis
Based on statistical and clinical significance, the following variables were selected for multivariate regression: GCS score at presentation, Hunt and Hess grade, days to admission, clinical vasospasm, cerebral edema, nosocomial infection, intubation, cardiovascular instability, rerupture, hyponatremia, ventriculitis, and treatment with antiepileptic drugs. The best-fitting multivariate logistic regression model included DCI as the dependent variable with clinical vasospasm, nosocomial infection, re-rupture, and ventriculitis as the independent variables. Multivariate analysis identified nosocomial infection (odds ratio [OR] 3.5, 95% confidence interval [CI] 1.09-11.2, p = 0.04), ventriculitis (OR 25.3, 95% CI 1.39-458.7, p = 0.03), re-rupture (OR 7.55, 95% CI 1.02-55.7, p = 0.05), and clinical vasospasm (OR 43.4, 95% CI 13.1-143.4, p < 0.01) as independent predictors of DCI (Table 2) .
outcome
Patients diagnosed with a nosocomial infection experienced poorer outcomes than patients not diagnosed with a nosocomial infection. Dichotomized (0-2 and 3-6) modified Rankin Scale (mRS) scores at discharge and 1 year were significantly different (p < 0.01 and p = 0.03, respectively) in patients with aSAH diagnosed with a nosocomial infection compared with those who were not (Table 3) .
Discussion
Delayed cerebral ischemia occurs in approximately 30% of patients with aSAH and contributes to poor outcome through vasospasm-dependent and -independent mechanisms. 28, 30, 31, 37 Early identification of those patients at increased risk has the potential to reduce neurological morbidity and mortality rates. An evolving understanding of the pathophysiology of symptomatic vasospasm and DCI has led to the identification of novel risk factors including systemic inflammation. 5, 15, 23 This study sought to assess the role of nosocomial infection with respect to DCI and outcome in patients presenting with aSAH.
Nosocomial Infection and DCI
Subarachnoid hemorrhage-induced immunodepression predisposes patients to bacterial infection and is most pronounced in neurologically symptomatic patients. 32 Nosocomial infections occur in approximately 26%-37% of patients with aSAH and contribute to poor outcome. 2, 9, 18 The current series experienced a nosocomial infection rate of 41%. Infection was identified as a statistically significant independent predictor of DCI with an OR of 3.5. While some authors have hypothesized that DCI predisposes patients to the development of nosocomial infection, 9 we contend that an additional clinical interplay is occurring. The majority of infection diagnoses preceded the diagnosis of DCI in the current series. Thus, we hypothesize that while DCI predisposes patients to infectious complications, infection predisposes patients to the development of DCI. Infection is a recognized precipitant of systemic inflammation leading to thrombocytosis, 11 leukocytosis, and release of inflammatory cytokines (namely, interleukin-6), 24 all of which have been implicated in the development of DCI. 5, 15, 22, 23 The role of systemic inflammation in the pathogenis of DCI involves increased concentration of adhesion molecules, cytokine-mediated vasoconstriction, upregulation of coagulation pathways, and downregulation of anticoagulation pathways. 20, 26, 38 Ventriculitis is a rare complication in patients with aSAH despite the frequent use of EVDs in the setting of SAH-induced immunodepression, occurring in approximately 1%-5% of patients (2.4% in the current series).
9,35
The development of ventriculitis was associated with a 25 times greater risk of DCI in the current series and preceded the diagnosis of DCI in 1 of 3 cases. Ventriculitis is most commonly a complication of prolonged external ventricular drainage. 16 Therefore, patients at highest risk for ventriculitis tend to be sicker patients requiring prolonged CSF diversion (i.e., high Hunt and Hess grades); these patients are also known to be at high risk for DCI, suggesting an association rather than causation. 1, 4 An alternative explanation could involve a marked inflammatory response within the CNS with subsequent intrathecal leukocytosis and cytokine release. 13, 33 This inflammation could contribute to DCI through similar mechanisms as systemic inflammation.
Further investigation into the temporal course of nosocomial infection, the systemic inflammatory response, and the development of DCI will need to be undertaken to better define a causative relationship. It is likely that causation is not linear, but rather a complex interplay between dynamic systems.
Nosocomial Infection and Outcome
Medical complications are common in patients with aSAH and contribute to poor outcome. 2, 9, 36, 39 Both blood stream infection and pneumonia have been identified as independent predictors of death or severe disability in aSAH. 9 While the association between nosocomial infection and poor outcome is intuitive, the potential pathophysiological mechanism proposed by the current series is novel. The poor outcomes associated with nosocomial infection in patients with aSAH may be related to a propensity for the development of DCI, an established poor prognostic indicator. 28, 31, 37 Aneurysm Re-Rupture and DCI
The re-rupture of an intracranial aneurysm is the most feared early complication in patients presenting with aSAH. The risk of re-rupture is nearly 20% in the first 24 hours, 10, 14 leading to guideline recommendations for early treatment. 3 Data regarding the effect of aneurysm re-rupture on the incidence of cerebral ischemia is mixed, with more recent data finding no difference. 12, 21 However, the present study identified aneurysm re-rupture as a statistically significant independent risk factor for DCI, with an OR of nearly 8. This finding is consistent with the association between increasing clot burden and increasing rates of vasospasm and DCI. 1, 8, 17 Clinical Vasospasm and DCI Clinical vasospasm occurred in 22.8% of the total study population and was independently associated with the development of DCI in multivariate analysis. This association is expected and has been identified in previous studies. 7, 29 Clinical vasospasm has been identified as a potentially treatable factor associated with infarction. 7 While focal clinical vasospasm may be easily appreciated through the identification of localizing signs, the more common diffuse vasospasm may present more insidiously. 29 Therefore a high index of suspicion must be maintained in an effort to quickly diagnose and treat prior to the development of cerebral infarction.
Limitations of the Study
This study has several limitations. The study population is relatively small, leading to concerns of statistical power. While DCI was defined as imaging evidence of cerebral infarction, the timing of diagnosis can vary. Symptomatic ischemia in neurologically well patients may be identified more quickly than symptomatic ischemia in neurologically ill patients or asymptomatic ischemia. This could lead to misinterpretation of the clinical timeline with regard to the diagnosis of infection and DCI. Another possibility is that the infection itself led to impaired neurological function, prompting increased surveillance in these patients. This has the potential to falsely elevate the rate of diagnosis of DCI in patients with infection. In addition, data on other parameters such as TCD results and clinical follow-up were lacking in some patients.
conclusions
Nosocomial infection is independently associated with the development of DCI in patients with aSAH. It is hypothesized that this association is, in part, causative with nosocomial infection predisposing patients to the development of DCI by exacerbating the systemic inflammatory response leading to thrombosis and subsequent ischemia.
